NUMAFERM GmbH was founded in 2017 as a spin-off of the Biochemistry Institute at the Heinrich-Heine University, Dusseldorf. The project was previously supported by an EXIST research transfer from the German Federal Ministry of Economics and Energy. The company offers its technology, related R&D services and a peptide catalogue focusing on pharmaceutical, antimicrobial and adhesives peptides.
Full speed ahead in the same boat – A talk about Simplaex and Numaferm’s cooperation
Evonik is investing in NUMAFERM, a specialist in the biotechnological production of peptides
NUMAFERM revolutionizes peptide production and receives seed financing